REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 1st, 2024 • Vaccinex, Inc. • Pharmaceutical preparations
Contract Type FiledApril 1st, 2024 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of March 29, 2024, by and between Vaccinex, Inc., a Delaware corporation (the “Company”), and Alzheimer’s Drug Discovery Foundation, a Delaware non-profit corporation (the “Investor”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 7th, 2024 • Vaccinex, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 7th, 2024 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of February 7, 2024, by and among Vaccinex, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 22nd, 2023 • Vaccinex, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 22nd, 2023 Company IndustryTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 20, 2023, by and among Vaccinex, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 22nd, 2023 • Vaccinex, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 22nd, 2023 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of August 18, 2023, by and among Vaccinex, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 25th, 2022 • Vaccinex, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 25th, 2022 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 22, 2022, by and between Vaccinex, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 31st, 2022 • Vaccinex, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 31st, 2022 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of January 31, 2022, by and between Vaccinex, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 10th, 2020 • Vaccinex, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 10th, 2020 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of July 10, 2020, by and between Vaccinex, Inc., a Delaware corporation (the “Company”), and Friedberg Global-Macro Hedge Fund Ltd. (the “Investor”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 23rd, 2020 • Vaccinex, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 23rd, 2020 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of January 23, 2020, by and between Vaccinex, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 31st, 2019 • Vaccinex, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 31st, 2019 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of July 30, 2019, by and between Vaccinex, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A (each an “Investor” and collectively the “Investors”).